Trials / Not Yet Recruiting
Not Yet RecruitingNCT07002749
ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- Sponsor
- Patel Hospital, Pakistan · Academic / Other
- Sex
- Female
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEXAMIC ACID IN PREVENTING PPH. THIS IS A RANDOMIZED CONTROLLED TRIAL. THE SAMPLING TECHNIQUE WOULD BE NON-PROBABILITY TECHNIQUE RANDOMIZATION WOULD BE DONE VIA BALLOTING METHOD.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tranexamic Acid (TXA) | I would like to see the effect of prophylactic tranexamic acid in women undergoing ELLSCS in preventing PPH in my setup. |
| DEVICE | Placebo | one group will get placebo |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2025-06-01
- Completion
- 2025-12-31
- First posted
- 2025-06-04
- Last updated
- 2025-06-04
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07002749. Inclusion in this directory is not an endorsement.